FDA Grants Breakthrough Device Designation for Closed-Loop tACS
Pulvinar Neuro, a wholly owned subsidiary of Electromedical Products International, Inc. (EPI), has received FDA Breakthrough Device designation for its Closed-Loop Transcranial Alternating Current Stimulation (tACS) device for the treatment of Major Depressive Disorder.